Unraveling the molecular repertoire of tears as a source of biomarkers: Beyond ocular diseases

Proteomics - Clinical Applications

Volumn 9, Issue 1-2, 2015, Pages 169-186

  Pieragostino, Damiana ^a   D'Alessandro, Michele ^a   di Ioia, Maria ^a   Di Ilio, Carmine ^a   Sacchetta, Paolo ^a   Del Boccio, Piero ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Lipidomics; Metabolomics; Tears biomarkers

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C3; CYSTATIN C; CYTOKINE; GELATINASE B; GLUCOSE; INTERSTITIAL COLLAGENASE; LACTOFERRIN; LATANOPROST; LIPOCALIN 1; LYSOPHOSPHOLIPID; MAMMAGLOBIN B; OLIGOCLONAL BAND; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN DERIVATIVE; PROSTANOID; SERUM ALBUMIN; EYE PROTEIN; PROTEOME;

BREAST CANCER; CHOROID MELANOMA; DIABETIC RETINOPATHY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRY EYE; ENDOCRINE OPHTHALMOPATHY; EYE DISEASE; EYE TUMOR; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KERATOCONJUNCTIVITIS SICCA; KERATOCONUS; LACRIMAL FLUID; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEIBOMIAN GLAND DYSFUNCTION; METABOLOMICS; MULTIPLE SCLEROSIS; OPEN ANGLE GLAUCOMA; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SJOEGREN SYNDROME; TREATMENT RESPONSE; ANIMAL; CHEMISTRY; EYE DISEASES; METABOLISM; PROCEDURES;

ANIMALS; BIOLOGICAL MARKERS; EYE DISEASES; EYE PROTEINS; HUMANS; METABOLOMICS; PROTEOME; PROTEOMICS; TEARS;

EID: 84922842929     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400084     Document Type: Review

References (120)

1. Tumani, H., Brettschneider, J., Biochemical markers of autoimmune diseases of the nervous system. Curr. Pharm. Des. 2012, 18, 4556-4563.
2. Butovich, I. A., Tear film lipids. Exp. Eye Res. 2013, 117, 4-27.
3. Zhou, L., Beuerman, R. W., Tear analysis in ocular surface diseases. Prog. Retin. Eye Res. 2012, 31, 527-550.
4. Chen, L., Zhou, L., Chan, E. C., Neo, J. et al., Characterization of the human tear metabolome by LC-MS/MS. J. Proteome Res. 2011, 10, 4876-4882.
5. Rantamaki, A. H., Seppanen-Laakso, T., Oresic, M., Jauhiainen, M. et al., Human tear fluid lipidome: from composition to function. PLoS One 2011, 6, e19553.
6. Sitaramamma, T., Shivaji, S., Rao, G. N., Effect of storage on protein concentration of tear samples. Curr. Eye Res. 1998, 17, 1027-1035.
7. Grus, F. H., Podust, V. N., Bruns, K., Lackner, K. et al., SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest. Ophthalmol. Vis. Sci. 2005, 46, 863-876.
8. Mulvenna, I., Stapleton, F., Hains, P. G., Cengiz, A. et al., Low molecular weight analysis of tears using matrix assisted laser desorption ionization-time of flight mass spectrometry. Clin. Experiment. Ophthalmol. 2000, 28, 205-207.
9. Kingshott, P., St John, H. A., Chatelier, R. C., Griesser, H. J., Matrix-assisted laser desorption ionization mass spectrometry detection of proteins adsorbed in vivo onto contact lenses. J. Biomed. Mater. Res. 2000, 49, 36-42.
10. Pieragostino, D., Bucci, S., Agnifili, L., Fasanella, V. et al., Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma. Mol. BiosSyst. 2012, 8, 1017-1028.
11. Herber, S., Grus, F. H., Sabuncuo, P., Augustin, A. J., Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis 2001, 22, 1838-1844.
12. Lema, I., Brea, D., Rodriguez-Gonzalez, R., Diez-Feijoo, E. et al., Proteomic analysis of the tear film in patients with keratoconus. Mol. Vis. 2010, 16, 2055-2061.
13. Csosz, E., Boross, P., Csutak, A., Berta, A. et al., Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy. J. Proteomics 2012, 75, 2196-2204.
14. Torok, Z., Peto, T., Csosz, E., Tukacs, E. et al., Tear fluid proteomics multimarkers for diabetic retinopathy screening. BMC Ophthalmol. 2013, 13, 40.
15. Zhou, L., Beuerman, R. W., Chan, C. M., Zhao, S. Z. et al., Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J. Proteome Res. 2009, 8, 4889-4905.
16. Masoudi, S., Zhong, L., Raftery, M. J., Stapleton, F. J., Willcox, M. D., Method development for quantification of five tear proteins using selected reaction monitoring (SRM) mass spectrometry. Invest. Ophthalmol. Vis. Sci. 2014, 55, 767-775.
17. Perumal, N., Funke, S., Pfeiffer, N., Grus, F. H., Characterization of lacrimal proline-rich protein 4 (PRR4) in human tear proteome. Proteomics 2014, 14, 1698-170914, 1698-1709.
18. Lei, Z., Beuerman, R. W., Chew, A. P., Koh, S. K. et al., Quantitative analysis of N-linked glycoproteins in tear fluid of climatic droplet keratopathy by glycopeptide capture and iTRAQ. J. Proteome Res. 2009, 8, 1992-2003.
19. Li, N., Wang, N., Zheng, J., Liu, X. M. et al., Characterization of human tear proteome using multiple proteomic analysis techniques. J. Proteome Res. 2005, 4, 2052-2061.
20. Wenk, M. R., Lipidomics: new tools and applications. Cell 2010, 143, 888-895.
21. Tang, D. Q., Zou, L., Yin, X. X., Ong, C. N., HILIC-MS for metabolomics: An attractive and complementary approach to RPLC-MS. Mass Spectrom. Rev. 2014.
22. Foster, J. M., Moreno, P., Fabregat, A., Hermjakob, H. et al., LipidHome: a database of theoretical lipids optimized for high throughput mass spectrometry lipidomics. PLoS One 2013, 8, e61951.
23. Ejsing, C. S., Duchoslav, E., Sampaio, J., Simons, K. et al., Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning. Anal. Chem. 2006, 78, 6202-6214.
24. Ekroos, K., Chernushevich, I. V., Simons, K., Shevchenko, A., Quantitative profiling of phospholipids by multiple precursor ion scanning on a hybrid quadrupole time-of-flight mass spectrometer. Anal. Chem. 2002, 74, 941-949.
25. Olsen, J. V., de Godoy, L. M., Li, G., Macek, B. et al., Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol. Cell. Proteomics 2005, 4, 2010-2021.
26. Thomas, M. C., Mitchell, T. W., Blanksby, S. J., OnLine ozonolysis methods for the determination of double bond position in unsaturated lipids. Methods Mol. Biol. 2009, 579, 413-441.
27. Schaumberg, D. A., Sullivan, D. A., Buring, J. E., Dana, M. R., Prevalence of dry eye syndrome among US women. Am. J. Ophthalmol. 2003, 136, 318-326.
28. von Thun Und Hohenstein-Blaul, N., Funke, S., Grus, F. H., Tears as a source of biomarkers for ocular and systemic diseases. Exp. Eye Res. 2013, 117, 126-137.
29. Boehm, N., Riechardt, A. I., Wiegand, M., Pfeiffer, N. et al., Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest. Ophthalmol. Vis. Sci. 2011, 52, 7725-7730.
30. Massingale, M. L., Li, X., Vallabhajosyula, M., Chen, D. et al., Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea 2009, 28, 1023-1027.
31. Solomon, A., Dursun, D., Liu, Z., Xie, Y. et al., Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest. Ophthalmol. Vis. Sci. 2001, 42, 2283-2292.
32. Caffery, B., Joyce, E., Boone, A., Slomovic, A. et al., Tear lipocalin and lysozyme in Sjogren and non-Sjogren dry eye. Optom. Vis. Sci. 2008, 85, 661-667.
33. D'Souza, S., Petznick, A., Tong, L., Hall, R. C. et al., Comparative analysis of two femtosecond LASIK platforms using iTRAQ quantitative proteomics. Invest. Ophthalmol. Vis. Sci. 2014, 55, 3396-3402.
34. Funke, S., Azimi, D., Wolters, D., Grus, F. H. et al., Longitudinal analysis of taurine induced effects on the tear proteome of contact lens wearers and dry eye patients using a RP-RP-Capillary-HPLC-MALDI TOF/TOF MS approach. J. Proteomics 2012, 75, 3177-3190.
35. Nichols, J. J., Green-Church, K. B., Mass spectrometry-based proteomic analyses in contact lens-related dry eye. Cornea 2009, 28, 1109-1117.
36. Versura, P., Nanni, P., Bavelloni, A., Blalock, W. L. et al., Tear proteomics in evaporative dry eye disease. Eye 2010, 24, 1396-1402.
37. Man Lam, S., Tong, L., Duan, X., Acharya, U. R. et al., Longitudinal changes in tear fluid lipidome brought about by eyelid-warming treatment in a cohort of meibomian gland dysfunction. J. Lipid Res. 2014, 55, 1959-1969.
38. Chotikavanich, S., de Paiva, C. S., Li de, Q., Chen, J. J. et al., Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest. Ophthalmol. Vis. Sci. 2009, 50, 3203-3209.
39. Sambursky, R., O'Brien, T. P., MMP-9 and the perioperative management of LASIK surgery. Curr. Opin. Ophthalmol. 2011, 22, 294-303.
40. Schiffman, R. M., Walt, J. G., Jacobsen, G., Doyle, J. J. et al., Utility assessment among patients with dry eye disease. Ophthalmology 2003, 110, 1412-1419.
41. Tsubota, K., Hirai, S., King, L. S., Agre, P. et al., Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjogren's syndrome. Lancet 2001, 357, 688-689.
42. Zhou, L., Wei, R., Zhao, P., Koh, S. K. et al., Proteomic analysis revealed the altered tear protein profile in a rabbit model of Sjogren's syndrome-associated dry eye. Proteomics 2013, 13, 2469-2481.
43. Janssen, P. T., van Bijsterveld, O. P., Tear fluid proteins in Sjogren's syndrome. Scand. J. Rheumatol. Suppl. 1986, 61, 224-227.
44. Da Dalt, S., Moncada, A., Priori, R., Valesini, G. et al., The lactoferrin tear test in the diagnosis of Sjogren's syndrome. Eur. J. Ophthalmol. 1996, 6, 284-286.
45. Tomosugi, N., Kitagawa, K., Takahashi, N., Sugai, S. et al., Diagnostic potential of tear proteomic patterns in Sjogren's syndrome. J. Proteome Res. 2005, 4, 820-825.
46. Toker, E., Yavuz, S., Direskeneli, H., Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjogren's syndrome. Br. J. Ophthalmol. 2004, 88, 384-387.
47. Yavuz, S., Toker, E., Bicakcigil, M., Mumcu, G. et al., Comparative analysis of autoantibodies against a-fodrin in serum, tear fluid, and saliva from patients with Sjogren's syndrome. J. Rheumatol. 2006, 33, 1289-1292.
48. Aluru, S. V., Agarwal, S., Srinivasan, B., Iyer, G. K. et al., Lacrimal proline rich 4 (LPRR4) protein in the tear fluid is a potential biomarker of dry eye syndrome. PLoS One 2012, 7, e51979.
49. Saijyothi, A. V., Angayarkanni, N., Syama, C., Utpal, T. et al., Two dimensional electrophoretic analysis of human tears: collection method in dry eye syndrome. Electrophoresis 2010, 31, 3420-3427.
50. Tsai, P. S., Evans, J. E., Green, K. M., Sullivan, R. M. et al., Proteomic analysis of human meibomian gland secretions. Br. J. Ophthalmol. 2006, 90, 372-377.
51. Boehm, N., Funke, S., Wiegand, M., Wehrwein, N., Pfeiffer, N., Grus, F. H., Alterations in the tear proteome of dry eye patients-a matter of the clinical phenotype. Invest. Ophthalmol. Vis. Sci. 2013, 54, 2385-2592.
52. Krachmer, J. H., Feder, R. S., Belin, M. W., Keratoconus and related noninflammatory corneal thinning disorders. Surv. Ophthalmol. 1984, 28, 293-322.
53. Rabinowitz, Y. S., Keratoconus. Surv. Ophthalmol. 1998, 42, 297-319.
54. Chandler, J. W., Immunology of the ocular surface. Int. Ophthalmol. Clin. 1985, 25, 13-23.
55. Bonini, S., Lambiase, A., Sgrulletta, R., Bonini, S., Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis. Curr. Opin. Allergy Clin. Immunol. 2003, 3, 381-387.
56. Zhou, L., Sawaguchi, S., Twining, S. S., Sugar, J. et al., Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest. Ophthalmol. Vis. Sci. 1998, 39, 1117-1124.
57. Collier, S. A., Madigan, M. C., Penfold, P. L., Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in normal and keratoconus corneas. Curr. Eye Res. 2000, 21, 662-668.
58. Lema, I., Duran, J. A., Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology 2005, 112, 654-659.
59. Pannebaker, C., Chandler, H. L., Nichols, J. J., Tear proteomics in keratoconus. Mol. Vis. 2010, 16, 1949-1957.
60. Li, D. Q., Pflugfelder, S. C., Matrix metalloproteinases in corneal inflammation. Ocul. Surf. 2005, 3, S198-202.
61. Shoshani, Y., Pe'er, J., Doviner, V., Frucht-Pery, J. et al., Increased expression of inflammatory cytokines and matrix metalloproteinases in pseudophakic corneal edema. Invest. Ophthalmol. Vis. Sci. 2005, 46, 1940-1947.
62. Seppala, H. P., Maatta, M., Rautia, M., Mackiewicz, Z. et al., EMMPRIN and MMP-1 in keratoconus. Cornea 2006, 25, 325-330.
63. Stoeckelhuber, M., Messmer, E. M., Schmidt, C., Xiao, F. et al., Immunohistochemical analysis of secretoglobin SCGB 2A1 expression in human ocular glands and tissues. Histochem. Cell Biol. 2006, 126, 103-109.
64. Acera, A., Vecino, E., Rodriguez-Agirretxe, I., Aloria, K. et al., Changes in tear protein profile in keratoconus disease. Eye 2011, 25, 1225-1233.
65. Balasubramanian, S. A., Pye, D. C., Willcox, M. D., Levels of lactoferrin, secretory IgA and serum albumin in the tear film of people with keratoconus. Exp. Eye Res. 2012, 96, 132-137.
66. Balasubramanian, S. A., Pye, D. C., Willcox, M. D., Are proteinases the reason for keratoconus? Curr. Eye Res. 2010, 35, 185-191.
67. Iskeleli, G., Karakoc, Y., Abdula, A., Tear film osmolarity in patients with thyroid ophthalmopathy. Jpn. J. Ophthalmol. 2008, 52, 323-326.
68. Khalil, H. A., de Keizer, R. J., Kijlstra, A., Analysis of tear proteins in Graves' ophthalmopathy by high performance liquid chromatography. Am. J. Ophthalmol. 1988, 106, 186-190.
69. Okrojek, R., Grus, F. H., Matheis, N., Kahaly, G. J., Proteomics in autoimmune thyroid eye disease. Horm. Metab. Res. 2009, 41, 465-470.
70. Jiang, L. H., Wei, R. L., Analysis of Graves' ophthalmopathy patients' tear protein spectrum. Chin. Med. J. (Engl.) 2013, 126, 4493-4498.
71. Cantin, A. M., Paquette, B., Richter, M., Larivee, P., Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation. Am. J. Respir. Crit. Care Med. 2000, 162, 1539-1546.
72. Ricklin, D., Hajishengallis, G., Yang, K., Lambris, J. D., Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11, 785-797.
73. Gerl, V. B., Bohl, J., Pitz, S., Stoffelns, B. et al., Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2002, 43, 1104-1108.
74. Jha, P., Banda, H., Tytarenko, R., Bora, P. S., Bora, N. S., Complement mediated apoptosis leads to the loss of retinal ganglion cells in animal model of glaucoma. Mol. Immunol. 2011, 48, 2151-2158.
75. Quigley, H. A., Number of people with glaucoma worldwide. Br. J. Ophthalmol. 1996, 80, 389-393.
76. Heijl, A., Leske, M. C., Bengtsson, B., Bengtsson, B. et al., Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol. Scand. 2003, 81, 286-293.
77. Pavlenko, T. A., Chesnokova, N. B., Davydova, H. G., Okhotsimskaia, T. D. et al., Level of tear endothelin-1 and plasminogen in patients with glaucoma and proliferative diabetic retinopathy. Vestn. Oftalmol. 2013, 129, 20-23.
78. Slepova, O. S., Frolov, M. A., Morozova, N. S., Frolov, A. M. et. al, Markers of Fas-mediated apoptosis in primary open-angle glaucoma and opportunities of their pharmacological correction. Vestn. Oftalmol. 2012, 128, 27-31.
79. Borovic, D., Bendelic, E., Chiselita, D., Study of kini-kallikrein and renin-angiotensin systems in patients with primary open angle glaucoma. Oftalmologia 2009, 53, 61-68.
80. Pieragostino, D., Agnifili, L., Fasanella, V., D'Aguanno, S. et al., Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naive to therapy. Mol. Biosyst 2013, 9, 1108-1116.
81. Openkova, Y. Y., Korobeiynikova, E. N., Rykin, V. S., Vinkova, G. A., The analysis of status of biochemical indicators in blood serum and lacrimal fluid in patients with primary open-angle glaucoma. Klin. Lab. Diagn. 2013, 8-11.
82. Lolli, F., Franciotta, D., Oligoclonal bands in tears. Mult. Scler. 2010, 16, 760; author reply 761.
83. Coyle, P. K., Sibony, P., Johnson, C., Oligoclonal IgG in tears. Neurology 1987, 37, 853-856.
84. Calais, G., Forzy, G., Crinquette, C., Mackowiak, A. et al., Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion. Mult. Scler. 2010, 16, 87-92.
85. Mavra, M., Thompson, E. J., Nikolic, J., Krunic, A. et al., The occurrence of oligoclonal IgG in tears from patients with MS and systemic immune disorders. Neurology 1990, 40, 1259-1262.
86. Martino, G., Servalli, C., Filippi, M., Buscemi, M. et al., Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients. J. Neuroimmunol. 1993, 44, 149-155.
87. Oehninger-Gatti, C., Buzo, R., Alcantara, J. C., Chouza, C. et al., The use of biological markers in the diagnosis and follow-up of patients with multiple sclerosis. Test of five fluids. Rev. Neurol. 2000, 30, 977-979.
88. Salvisberg, C., Tajouri, N., Hainard, A., Burkhard, P. R. et al., Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis. Proteomics Clin. Appl. 2014, 8, 185-194.
89. Eliassi-Rad, B., Albert, D. M., Green, W. R., Frequency of ocular metastases in patients dying of cancer in eye bank populations. Br. J. Ophthalmol. 1996, 80, 125-128.
90. de Freitas Campos, C., Cole, N., Van Dyk, D., Walsh, B. J. et al., Proteomic analysis of dog tears for potential cancer markers. Res. Vet. Sci. 2008, 85, 349-352.
91. Dikovskaya, M. A., Trunov, A. N., Chernykh, V. V., Korolenko, T. A., Cystatin C and lactoferrin concentrations in biological fluids as possible prognostic factors in eye tumor development. Int. J. Circumpolar Health 2013, 72.
92. Lebrecht, A., Boehm, D., Schmidt, M., Koelbl, H. et al., Diagnosis of breast cancer by tear proteomic pattern. Cancer Genomics Proteomics 2009, 6, 177-182.
93. Bohm, D., Keller, K., Pieter, J., Boehm, N. et al., Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach. Oncol. Rep. 2012, 28, 429-438.
94. Lebrecht, A., Boehm, D., Schmidt, M., Koelbl, H. et al., Surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry to detect breast cancer markers in tears and serum. Cancer Genomics Proteomics 2009, 6, 75-83.
95. Pin, E., Fredolini, C., Petricoin, E. F., 3rd, The role of proteomics in prostate cancer research: biomarker discovery and validation. Clin. Biochem. 2013, 46, 524-538.
96. Smith, R. A., Cokkinides, V., Eyre, H. J., American Cancer, S., American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J. Clin. 2003, 53, 27-43.
97. Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S. et al., The influence of finasteride on the development of prostate cancer. N. Engl. J. Med. 2003, 349, 215-224.
98. Thompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M. et al., Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N. Engl. J. Med. 2004, 350, 2239-2246.
99. Chen, J., Zhang, D., Yan, W., Yang, D. et al., Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era. BioMed Res. Int. 2013, 2013, 901578.
100. Li, Y., Cozzi, P.J., Zhao, J., Walsh, B. J. et al., Identification of novel biomarkers in tears for prostate cancer diagnosis and prognosis. AACR 2007.
101. Yau, J. W., Rogers, S. L., Kawasaki, R., Lamoureux, E. L. et al., Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012, 35, 556-564.
102. Heng, L. Z., Comyn, O., Peto, T., Tadros, C. et al., Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet. Med. 2013, 30, 640-650.
103. Stolwijk, T. R., Kuizenga, A., van Haeringen, N. J., Kijlstra, A. et al., Analysis of tear fluid proteins in insulin-dependent diabetes mellitus. Acta Ophthalmol. (Copenh.) 1994, 72, 357-362.
104. Yu, L., Chen, X., Qin, G., Xie, H. et al., Tear film function in type 2 diabetic patients with retinopathy. Ophthalmologica 2008, 222, 284-291.
105. Li, B., Sheng, M., Xie, L., Liu, F. et al., Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry. Invest. Ophthalmol. Vis. Sci. 2014, 55, 177-186.
106. Rakov, S. S., Ochirova, E. P., Moshetova, L. K., Protein markers of diabetic retinopathy. Klin. Lab. Diagn. 2002, 7-10.
107. Shine, W. E., McCulley, J. P., Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality. Arch. Ophthalmol. 1998, 116, 849-852.
108. Butovich, I. A., On the lipid composition of human meibum and tears: comparative analysis of nonpolar lipids. Invest. Ophthalmol. Vis. Sci. 2008, 49, 3779-3789.
109. Butovich, I. A., Wojtowicz, J. C., Molai, M., Human tear film and meibum. Very long chain wax esters and (O-acyl)-omega-hydroxy fatty acids of meibum. J. Lipid Res. 2009, 50, 2471-2485.
110. Wakamatsu, T. H., Dogru, M., Matsumoto, Y., Kojima, T. et al., Evaluation of lipid oxidative stress status in Sjogren syndrome patients. Invest. Ophthalmol. Vis. Sci. 2013, 54, 201-210.
111. Lam, S. M., Tong, L., Duan, X., Petznick, A. et al., Extensive characterization of human tear fluid collected using different techniques unravels the presence of novel lipid amphiphiles. J. Lipid Res. 2014, 55, 289-298.
112. Lam, S. M., Tong, L., Duan, X., Acharya, U. R. et al., Longitudinal changes in the levels of tear fluid lysophospholipids and O-acyl-omega-hydroxy fatty acids brought about by eyelid-warming treatment in a cohort of Meibomian Gland Dysfunction patients. J. Lipid Res. 2014.
113. Dean, A. W., Glasgow, B. J., Mass spectrometric identification of phospholipids in human tears and tear lipocalin. Invest. Ophthalmol. Vis. Sci. 2012, 53, 1773-1782.
114. Pescosolido, N., Imperatrice, B., Koverech, A., Messano, M., L-carnitine and short chain ester in tears from patients with dry eye. Optom. Vis. Sci. 2009, 86, E132-E138.
115. Nakatsukasa, M., Sotozono, C., Shimbo, K., Ono, N. et al., Amino Acid profiles in human tear fluids analyzed by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry. Am. J. Ophthalmol. 2011, 151, 799-808 e791.
116. Baca, J. T., Taormina, C. R., Feingold, E., Finegold, D. N. et al., Mass spectral determination of fasting tear glucose concentrations in nondiabetic volunteers. Clin. Chem. 2007, 53, 1370-1372.
117. An, H. J., Ninonuevo, M., Aguilan, J., Liu, H. et al., Glycomics analyses of tear fluid for the diagnostic detection of ocular rosacea. J. Proteome Res. 2005, 4, 1981-1987.
118. Lopilly Park, H. Y., Kim, J. H., Lee, K. M., Park, C. K., Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and cornea. Exp. Eye Res. 2012, 94, 13-21.
119. Wong, T. T., Zhou, L., Li, J., Tong, L. et al., Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication. Invest. Ophthalmol. Vis. Sci. 2011, 52, 7385-7391.
120. Pinazo-Duran, M. D., Galbis-Estrada, C., Pons-Vazquez, S., Cantu-Dibildox, J. et al., Effects of a nutraceutical formulation based on the combination of antioxidants and omega-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders. Clin. Interv. Aging 2013, 8, 139-148.